{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:08:02Z","timestamp":1784293682961,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jdiacomp.2025.109017","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T20:41:45Z","timestamp":1743540105000},"page":"109017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inflammation levels in type 2 diabetes mellitus patients with mild cognitive impairment: Assessment followed by amelioration via dapagliflozin therapy"],"prefix":"10.1016","volume":"39","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianrong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2025.109017_bb0005","series-title":"IDF diabetes Atlas 2021","author":"International Diabetes Federation","year":"2021"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0010","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1001\/jama.2021.22208","article-title":"Prevalence and treatment of diabetes in China, 2013-2018","volume":"326","author":"Wang","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0015","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00592-020-01648-9","article-title":"The prevalence of mild cognitive impairment in type 2 diabetes mellitus patients: a systematic review and meta-analysis","volume":"58","author":"You","year":"2021","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.100944","article-title":"Diabetes mellitus and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 144 prospective studies","volume":"55","author":"Xue","year":"2019","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108939","article-title":"Cognitive function among older adults with diabetes and prediabetes, NHANES 2011-2014","volume":"178","author":"Casagrande","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.pcd.2019.11.005","article-title":"Cognitive impairment in elderly people with prediabetes or diabetes: a cross-sectional study of the NHANES population","volume":"14","author":"Cichosz","year":"2020","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0035","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/alz.12482","article-title":"The impact of diabetes on cognitive impairment and its progression to dementia","volume":"17","author":"Dove","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0040","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrendo.2010.228","article-title":"Cognitive function, dementia and type 2 diabetes mellitus in the elderly","volume":"7","author":"Strachan","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0045","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41580-021-00390-6","article-title":"The aetiology and molecular landscape of insulin resistance","volume":"22","author":"James","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0050","doi-asserted-by":"crossref","first-page":"R927","DOI":"10.1152\/ajpregu.00482.2016","article-title":"TLR2 knockout protects against diabetes-mediated changes in cerebral perfusion and cognitive deficits","volume":"312","author":"Hardigan","year":"2017","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fncel.2019.00017","article-title":"The link between tau and insulin signaling: implications for Alzheimer\u2019s disease and other tauopathies","volume":"13","author":"Gon\u00e7alves","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0060","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.2147\/DMSO.S271160","article-title":"Association between inflammatory biomarkers and cognitive dysfunction analyzed by MRI in diabetes patients","volume":"13","author":"Yang","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/biof.1998","article-title":"Dapagliflozin improves diabetic cognitive impairment via indirectly modulating the mitochondria homeostasis of hippocampus in diabetic mice","volume":"50","author":"Gui","year":"2024","journal-title":"Biofactors"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0070","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0075","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0080","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/0891988711422528","article-title":"Montreal cognitive assessment in detecting cognitive impairment in Chinese elderly individuals: a population-based study","volume":"24","author":"Lu","year":"2011","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0085","article-title":"The China Alzheimer report 2022","volume":"35","author":"Ren","year":"2022","journal-title":"Gen Psychiatr"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-2667(20)30185-7","article-title":"Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study","volume":"5","author":"Jia","year":"2020","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0095","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0100","article-title":"Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study","volume":"369","author":"Li","year":"2020","journal-title":"Bmj"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/alz.12629","article-title":"Mild cognitive impairment among rural-dwelling older adults in China: a community-based study","volume":"19","author":"Cong","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0110","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1111\/jgs.17985","article-title":"Mediation effects of diabetes and inflammation on the relationship of obesity to cognitive impairment in African Americans","volume":"70","author":"Abi Saleh","year":"2022","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0115","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgab135","article-title":"Association between midlife obesity and its metabolic consequences, cerebrovascular disease, and cognitive decline","volume":"106","author":"Morys","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09390","article-title":"Brain structural alterations detected by an automatic quantified tool as an indicator for MCI diagnosing in type 2 diabetes mellitus patients: a magnetic resonance imaging study","volume":"8","author":"Gu","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0125","first-page":"12","article-title":"Association between brain imaging biomarkers and continuous glucose monitoring-derived glycemic control indices in Japanese patients with type 2 diabetes mellitus","author":"Inoue","year":"2024","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.904468","article-title":"Lterations of cerebral blood flow and its connectivity in olfactory-related brain regions of type 2 diabetes mellitus patients","volume":"16","author":"Luo","year":"2022","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0135","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41598-023-50768-z","article-title":"White matter microstructure alterations in type 2 diabetes mellitus and its correlation with cerebral small vessel disease and cognitive performance","volume":"14","author":"Liu","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.comppsych.2017.07.003","article-title":"Risk factors of transition from mild cognitive impairment to Alzheimer\u2019s disease and death: a cohort study","volume":"78","author":"Xue","year":"2017","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0145","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jpsychires.2021.11.041","article-title":"Prevalence, risk and protective factors for mild cognitive impairment in a population-based study of Singaporean elderly","volume":"145","author":"Liu","year":"2021","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.23736\/S0021-9509.23.12620-6","article-title":"Asymptomatic carotid stenosis and cognitive impairment","volume":"64","author":"Paraskevas","year":"2023","journal-title":"J Cardiovasc Surg"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0155","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1161\/STROKEAHA.107.496737","article-title":"Microemboli composed of cholesterol crystals disrupt the blood-brain barrier and reduce cognition","volume":"39","author":"Rapp","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0160","doi-asserted-by":"crossref","first-page":"6634537","DOI":"10.1155\/2020\/6634537","article-title":"Effects of carotid artery stent and carotid endarterectomy on cognitive function in patients with carotid stenosis","volume":"2020","author":"Huang","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0165","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1573399814666180423113341","article-title":"Role of inflammatory markers in elderly type 2 diabetic patients with mild cognitive impairment","volume":"15","author":"Hosny","year":"2019","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0170","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00125-021-05634-w","article-title":"Higher baseline inflammatory marker levels predict greater cognitive decline in older people with type 2 diabetes: year 10 follow-up of the Edinburgh type 2 diabetes study","volume":"65","author":"Sluiman","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0175","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.brainres.2016.05.013","article-title":"Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice","volume":"1644","author":"Oliveira","year":"2016","journal-title":"Brain Res"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0180","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12933-022-01685-4","article-title":"Endothelial biomarkers and platelet reactivity on ticagrelor versus clopidogrel in patients after acute coronary syndrome with and without concomitant type 2 diabetes: a preliminary observational study","volume":"21","author":"Chyrchel","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0185","first-page":"12","article-title":"Vascular cell adhesion molecule-1 as an inflammation-related biomarker of coronary slow flow","author":"Zhu","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0190","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1053\/euhj.2002.3188","article-title":"Prediction of cardiovascular risk using soluble cell adhesion molecules","volume":"23","author":"Mulvihill","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0195","first-page":"560","article-title":"Elevated soluble vascular cell adhesion molecule-1 is associated with cerebrovascular resistance and cognitive function","volume":"72","author":"Tchalla","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0200","article-title":"Interleukin-1\u03b2 induces blood-brain barrier disruption by downregulating sonic hedgehog in astrocytes","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0205","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120433","article-title":"Serum levels of inflammatory markers in depressed elderly patients with diabetes and mild cognitive impairment","volume":"10","author":"Gorska-Ciebiada","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12902-019-0402-3","article-title":"Relationship between inflammatory markers and mild cognitive impairment in Chinese patients with type 2 diabetes: a case-control study","volume":"19","author":"Zheng","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinbiochem.2023.110683","article-title":"Correlation between inflammatory biomarkers, cognitive function and glycemic and lipid profiles in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"121-122","author":"Du","year":"2023","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0225","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11011-015-9739-0","article-title":"Adiponectin, leptin and IL-1 \u03b2 in elderly diabetic patients with mild cognitive impairment","volume":"31","author":"Gorska-Ciebiada","year":"2016","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0230","first-page":"28","article-title":"Designing new sport supplements based on Aronia melanocarpa and bee pollen to enhance antioxidant capacity and nutritional value","author":"Tirla","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0235","doi-asserted-by":"crossref","first-page":"C240","DOI":"10.1152\/ajpcell.00317.2012","article-title":"Regional distribution of SGLT activity in rat brain in vivo","volume":"304","author":"Yu","year":"2013","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0240","doi-asserted-by":"crossref","first-page":"14379","DOI":"10.1074\/jbc.REV120.008387","article-title":"Sodium-glucose cotransporter-2 inhibitors: understanding the mechanisms for therapeutic promise and persisting risks","volume":"295","author":"Perry","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0245","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1152\/physrev.00055.2009","article-title":"Biology of human sodium glucose transporters","volume":"91","author":"Wright","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106062","article-title":"Cognitive impairment and type 2 diabetes mellitus: focus of SGLT2 inhibitors treatment","volume":"176","author":"Rizzo","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0255","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1021\/acschemneuro.0c00722","article-title":"Targeting ROS-dependent AKT\/GSK-3\u03b2\/NF-\u03baB and DJ-1\/Nrf2 pathways by dapagliflozin attenuates neuronal injury and motor dysfunction in rotenone-induced Parkinson\u2019s disease rat model","volume":"12","author":"Arab","year":"2021","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0260","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/biomedicines12010036","article-title":"SGLT2 inhibitor canagliflozin alleviates high glucose-induced inflammatory toxicity in BV-2 microglia","volume":"12","author":"Lee","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0265","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1161\/HYPERTENSIONAHA.122.19586","article-title":"SGLT2 inhibition via empagliflozin improves endothelial function and reduces mitochondrial oxidative stress: insights from frail hypertensive and diabetic patients","volume":"79","author":"Mone","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.jdiacomp.2025.109017_bb0270","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.brainresbull.2022.01.017","article-title":"Dapagliflozin diminishes memory and cognition impairment in Streptozotocin induced diabetes through its effect on Wnt\/\u03b2-catenin and CREB pathway","volume":"181","author":"El-Safty","year":"2022","journal-title":"Brain Res Bull"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725000704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725000704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:05:17Z","timestamp":1762362317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872725000704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1056872725000704"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109017","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation levels in type 2 diabetes mellitus patients with mild cognitive impairment: Assessment followed by amelioration via dapagliflozin therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109017"}}